Suppr超能文献

在西班牙一家角膜移植转诊中心,对原发性失败的 Descemet 膜内皮角膜移植进行重复 Descemet 膜内皮角膜移植:DIMOEK 研究。

Repeat Descemet Membrane Endothelial Keratoplasty for Failed Primary Descemet Membrane Endothelial Keratoplasty at a Referral Center for Keratoplasty in Spain: DIMOEK Study.

机构信息

Instituto Microcirugía Ocular, Barcelona, Spain.

Instituto Microcirugía Ocular, Barcelona, Spain; Universidad Autónoma de Barcelona, Barcelona, Spain.

出版信息

Am J Ophthalmol. 2020 Jul;215:49-55. doi: 10.1016/j.ajo.2020.03.015. Epub 2020 Mar 21.

Abstract

PURPOSE

To analyze the clinical results of repeat Descemet membrane endothelial keratoplasty (re-DMEK) for failed primary DMEK graft at a referral center for keratoplasty in Spain.

DESIGN

Retrospective, interventional, comparative case series.

METHODS

From a single-center, single-surgeon series of 189 consecutive DMEK surgeries, 14 (7.41%) were re-DMEK eyes. The primary outcome was best-corrected visual acuity change (ΔBCVA, logarithm of minimal angle of resolution [logMAR]) from baseline (before first DMEK) to last follow-up. Secondary outcomes were ΔBCVA from baseline at 3, 6, and 12 months postoperatively, endothelial cell loss (%ECL), rebubbling rate, and re-DMEK graft failure. Outcomes were compared with an age-matched control group of 18 successful primary DMEK eyes.

RESULTS

After re-DMEK (median follow-up time 14.5 [42.5] months), mean BCVA improved from 0.55 (0.42) logMAR (Snellen 20/71 [20/53]) at baseline to 0.09 (0.26) logMAR (Snellen 20/25 [20/36]; P = .037). ΔBCVA from baseline was statistically significant at months 3 (P = .028), 6 (P = .023), and 12 (P = .012), and ΔBCVA was significant observed between months 6 and 12 (P = .028). BCVA differences between patient groups were statistically nonsignificant at 3 (P = .397), 6 (P = .468), and 12 months (P = .647). Mean %ECL in re-DMEK eyes with follow-up ≥12 months was 48.2 (15.1%), and the rebubbling rate was 28.6%; differences between groups were statistically nonsignificant for both variables (P = .580 and P = .669, respectively). Three re-DMEK eyes developed graft failure, all achieving final BCVA ≤0.30 logMAR (Snellen ≥20/40) after tertiary keratoplasty.

CONCLUSIONS

Repeat DMEK produces significant, continuous visual improvement after failed primary DMEK. Although visual outcomes and %ECL were comparable to primary DMEK, there was a relatively high rate of graft failure after re-DMEK.

摘要

目的

分析西班牙一家角膜移植转诊中心初次失败的后弹力层内皮角膜移植(re-DMEK)的临床结果。

设计

回顾性、干预性、比较病例系列。

方法

在 189 例连续的 DMEK 手术中,有 14 例(7.41%)为 re-DMEK 眼。主要结局是最佳矫正视力变化(ΔBCVA,最小角分辨率对数[logMAR]),从基线(初次 DMEK 之前)到最后一次随访。次要结局是术后 3、6 和 12 个月时的 ΔBCVA、内皮细胞丢失(%ECL)、复泡率和 re-DMEK 移植物失败。将这些结果与 18 例初次成功的 DMEK 眼的年龄匹配对照组进行比较。

结果

在 re-DMEK 后(中位随访时间 14.5[42.5]个月),平均 BCVA 从基线时的 0.55(0.42)logMAR(Snellen 20/71 [20/53])改善至 0.09(0.26)logMAR(Snellen 20/25 [20/36];P=.037)。基线时的 ΔBCVA 在术后 3 个月(P=.028)、6 个月(P=.023)和 12 个月(P=.012)时具有统计学意义,并且 6 个月和 12 个月时的 ΔBCVA 有显著差异(P=.028)。两组患者在 3 个月(P=.397)、6 个月(P=.468)和 12 个月时(P=.647)的 BCVA 差异无统计学意义。在 re-DMEK 眼随访≥12 个月时,平均 %ECL 为 48.2(15.1%),复泡率为 28.6%;两组在这两个变量上的差异均无统计学意义(P=.580 和 P=.669)。有 3 只 re-DMEK 眼发生移植物失败,在接受三次性角膜移植后,最终 BCVA 均≤0.30 logMAR(Snellen ≥20/40)。

结论

初次失败的后弹力层内皮角膜移植(re-DMEK)后可显著、持续改善视力。尽管 re-DMEK 的视力结果和 %ECL 与初次 DMEK 相当,但 re-DMEK 后移植物失败的相对风险较高。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验